Kaya Reports FY26 Net Loss, Q4 Revenue Rises
Kaya Limited announced its audited financial results for the quarter and year ended March 31, 2026, reporting a consolidated net loss of INR 961.73 crore for the full year compared to a profit in the previous year. For Q4 FY26, revenue rose 2% to INR 55.8 crore, though the company posted a net loss of INR 27.77 crore. The board approved the extension of loans from directors and noted the completion of the voluntary liquidation of a subsidiary.
*this image is generated using AI for illustrative purposes only.
Kaya Limited has announced its audited financial results for the quarter and financial year ended March 31, 2026. The Board of Directors approved the standalone and consolidated results at a meeting held on May 20, 2026. The statutory auditors issued an unmodified opinion on the financial results. The company also disclosed that the newspaper extract of these audited consolidated financial results was published on May 21, 2026, in Financial Express and Mumbai Lakshadeep.
Financial Performance
For the quarter ended March 31, 2026, revenue from operations stood at INR 55.8 crore, representing a 2% increase compared to INR 54.7 crore in the corresponding quarter of the previous year. The company reported a net loss of INR 27.77 crore for the quarter at both standalone and consolidated levels. This loss includes a one-time impairment loss of INR 11.8 crore on Property, Plant and Equipment and a gain of INR 3.7 crore from the impact of labour codes.
For the full financial year ended March 31, 2026, the company reported a consolidated net loss of INR 961.73 crore compared to a net profit of INR 836.75 crore in the previous year. Revenue from operations for the year increased to INR 2,224.76 crore from INR 2,171.68 crore in the prior year.
| Particulars | Q4FY26 | Q4FY25 |
|---|---|---|
| Revenue from operations | 55.8 | 54.7 |
| Profit/(Loss) after tax | (27.77) | (7.02) |
Operational Highlights
The clinic business registered a 7% growth in revenue over Q4 FY25. The services business grew by 5%, driven by categories such as Acne & Scars, Hair Care, Brightening & Pigmentation, and Anti-Aging. Specifically, Acne & Scars services witnessed a 52% growth, while Haircare services grew by 20%. Brightening & Pigmentation showed a strong growth of 28%, while Anti-Aging grew by 8%. The Product business registered a 21% growth over Q4 FY25, led by Nutraceutical, Lighter and Brighter, and Anti-Aging categories.
Board Decisions
The board approved the extension of loans availed from Directors Mr. Harsh Mariwala and Mr. Rajendra Mariwala. The loans, amounting to INR 16.19 crore each, were extended for a period of seven years. Additionally, the board noted the completion of the voluntary liquidation process of its wholly-owned subsidiary, KME Holdings Pte. Limited, effective April 22, 2026.
Historical Stock Returns for Kaya
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.32% | +2.37% | -2.98% | -36.03% | -23.40% | -30.49% |
How will Kaya Limited plan to address its massive consolidated net loss of INR 961.73 crore in FY26, and what restructuring measures might the company undertake to return to profitability?
Given the strong growth in Acne & Scars (52%) and Brightening & Pigmentation (28%) service categories, will Kaya consider expanding its clinic network or investing further in these high-performing segments?
With the voluntary liquidation of KME Holdings Pte. Limited completed, does Kaya plan to exit other international markets or consolidate its overseas operations further?
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
